listN: 1101

This data as json

EPA_reg_num Risk_level Active_ingredient Product_name Company Use_site Surface_type Contact_time Formulation_type Date_on_List_N Why_on_List_N ID
6836-152 Increased Risk Quaternary ammonium Lonza Formulation DC-103 Arxada, LLC Healthcare; Institutional; Residential Hard Nonporous (HN) 1.0 minutes Ready-to-use 2021-04-13 Tested against SARS-CoV-2 (COVID-19); Emerging viral pathogen claim 1101